Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

The researchers found that at week 40, the change from baseline in HbA1c was −1.44 and −0.67% with tirzepatide and dulaglutide escalation to 4.5 mg or maximum tolerated dose, respectively.

16% of the control group ... from the SECURE-T2D trial revealed the system led to large reductions in HbA1c at 13 weeks for adults with type 2 diabetes. Unlike SECURE-T2D, which was a single ...